PaulJLimburgMD
Gastroenterology • Rochester, MNGastrointestinal Cancer
Professor, Internal Medicine, Mayo Medical School
Dr. Limburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-266-0350
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1994 - 1997- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1991 - 1994
- Mayo Clinic College of MedicineClass of 1991
Certifications & Licensure
MN State Medical License 1992 - 2024
AZ State Medical License 1997 - 1998- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2011
- Fellow (AGAF) American Gastroenterological Association, 2011
Clinical Trials
- Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers Start of enrollment: 2006 Apr 01
- Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia Start of enrollment: 2008 Nov 01
- Studying Different Formulations of SR13668 in Healthy Volunteers Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsNext-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.Thomas F Imperiale, Kyle Porter, Julia Zella, Zubin D Gagrat, Marilyn C Olson
The New England Journal of Medicine. 2024-03-14 - Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.Kenneth K Tanabe, David Zahrieh, Carrie A Strand, Yujin Hoshida, Thomas J Flotte
Gastro Hep Advances. 2024-01-01 - 4 citationsPhase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection.Jeffrey M Jacobson, David Zahrieh, Carrie A Strand, Marcia Cruz-Correa, Surakit Pungpapong
Cancer Prevention Research. 2023-03-01
Press Mentions
Blood-Based Colorectal Cancer Tests Show 88% SensitivitySeptember 16th, 2024- Exact Sciences Presents Data Demonstrating Advancement in Blood-Based Colorectal Cancer Screening at ESMO 2024September 16th, 2024
- Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual MeetingMay 9th, 2023
- Join now to see all
Grant Support
- Molecular Epidemiology Of Colorectal Cancer SubtypesNational Cancer Institute2005–2010
- Phase 1 And Phase 2 Clinical Trials Of Cancer Chemopreventive AgentsNational Cancer Institute2007
- Insulin, The IGF Axis, And Colorectal NeoplasiaNational Cancer Institute2004–2005
- Pre-Endoscopy Survey Of Risk Factors For GI ConditionsNational Center For Research Resources2004
- Insulin, The IGF Axis, And Colorectal NeoplasiaNational Cancer Institute2001–2003
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
